Opinion|Videos|October 25, 2023

Abiraterone’s Role in the Management of Prostate Cancer

Author(s)Benjamin H. Lowentritt, MD, FACS

Benjamin H. Lowentritt, MD, FACS, provides clinical insights on the use of different formulations of abiraterone as treatment for patients with prostate cancer.

Episodes in this series

Benjamin H. Lowentritt, MD, FACS, an expert on prostate cancer

EP. 1 Overview of Abiraterone Options for Patients with Prostate Cancer

Benjamin H. Lowentritt, MD, FACS, an expert on prostate cancer

EP. 2 Abiraterone Formulations for Patients With Prostate Cancer

Benjamin H. Lowentritt, MD, FACS, an expert on prostate cancer

EP. 3 Abiraterone’s Role in the Management of Prostate Cancer

Benjamin H. Lowentritt, MD, FACS, an expert on prostate cancer

EP. 4 Prostate Cancer Treatment: Incorporating Micronized Abiraterone into Clinical Practice

Paul E. Dato, MD, an expert on prostate cancer

EP. 5 Treating mCRPC as a Multidisciplinary Team

Paul E. Dato, MD, an expert on prostate cancer

EP. 6 Multidisciplinary Care for Patients With mCRPC

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

The role of diet and lifestyle in prostate cancer care, with Lorelei A. Mucci, ScD, MPH

ByLorelei A. Mucci, ScD, MPH

September 11th 2026

Doublet or triplet? Urologists weighs in on mCSPC options

ByUrology Times staff

September 10th 2026

Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD

ByMartin Schoen, MD, PhD,Hannah Clarke

September 10th 2026

App-based intervention aims to increase PSA screening among Black men

ByHannah Clarke

September 9th 2026

The critical role of advocacy in urologic oncology

ByRuchika Talwar, MD,Lan Anh Galloway, MD

September 9th 2026

Latest CME

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Jeremie Calais, MD, PhD; Scott T. Tagawa, MD, MS, FACP, FASCO

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

AI-generated profiles impersonate female urologists to market ED products online

Alternative BCG strains may help address ongoing supply challenges in NMIBC

Doublet or triplet? Urologists weighs in on mCSPC options

Pearls & Perspectives: Sexual Health and Intimacy in Midlife, With Karen Bigman, MBA

Prior auth, step therapy, and consolidation pressure: Independent urology's challenge